Home Other Building Blocks 15029-32-0
15029-32-0,MFCD00023353
Catalog No.:AA001MEQ

15029-32-0 | N-Cyanoacetylmorpholine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
99%
in stock  
$29.00   $20.00
- +
5g
99%
in stock  
$36.00   $25.00
- +
25g
99%
in stock  
$86.00   $60.00
- +
100g
99%
in stock  
$293.00   $205.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001MEQ
Chemical Name:
N-Cyanoacetylmorpholine
CAS Number:
15029-32-0
Molecular Formula:
C7H10N2O2
Molecular Weight:
154.1665
MDL Number:
MFCD00023353
SMILES:
N#CCC(=O)N1CCOCC1
NSC Number:
22791
Properties
Properties
 
BP:
230.8°C at 760 mmHg  
Form:
Solid  
MP:
87 °C  
Refractive Index:
1.4880 (estimate)  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
188  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
1  
XLogP3:
-0.8  

Downstream Synthesis Route

[1]Riddles,CourtneyN.;Whited,Mark;Lotlikar,ShalakaR.;Still,Korey;Patrauchan,Marianna;Silchenko,Svitlana;Gerasimchuk,Nikolay[InorganicaChimicaActa,2014,vol.412,p.94-103]

[2]Price,KristinE.;Larrivee-Aboussafy,Claude;Lillie,BrettM.;McLaughlin,RobertW.;Mustakis,Jason;Hettenbach,KevinW.;Hawkins,JoelM.;Vaidyanathan,Rajappa[OrganicLetters,2009,vol.11,#9,p.2003-2006]

[3]Adepu,Raju;Sunke,Rajnikanth;Meda,ChandanaL.T.;Rambabu;Krishna,G.Rama;Reddy,C.Malla;Deora,GirdharSingh;Parsa,KishoreV.L.;Pal,Manojit[ChemicalCommunications,2013,vol.49,#2,p.190-192]

[4]CurrentPatentAssignee:PFIZERINC-US2005/159446,2005,A1Locationinpatent:Page/Pagecolumn11

[5]Locationinpatent:experimentalpartMoghaddam,FirouzMatloubi;Bardajee,GhasemRezanejade;Dolabi,Maliheh[JournalofSulfurChemistry,2010,vol.31,#5,p.387-393]

[6]Shaik,JeelanBasha;Yeggoni,DanielPushparaju;Kandrakonda,YelamandaRao;Penumala,Mohan;Zinka,RaveendraBabu;Kotapati,KasiViswanath;Darla,MarkManidhar;Ampasala,DinakaraRao;Subramanyam,Rajagopal;Amooru,DamuGangaiah[BioorganicChemistry,2019,vol.88]

[7]CurrentPatentAssignee:NATIONALINSTITUTEOFBIOLOGICALSCIENCES;NATINSTITUTEOFBIOLOGICALSCIENCESBEIJING-WO2016/206573,2016,A1Locationinpatent:Paragraph0116;0117;0118

[8]Whitehead;Traverso[JournaloftheAmericanChemicalSociety,1955,vol.77,p.5872,5875]

[9]Bhawal,BaburaoM.;Khanapure,SubhashP.;Biehl,EdwardR.[SyntheticCommunications,1990,vol.20,#20,p.3235-3243]

[10]CurrentPatentAssignee:ABBVIEINC-US2004/167128,2004,A1Locationinpatent:Page100

[11]CurrentPatentAssignee:ABBOTTLABORATORIESINC-US2004/157836,2004,A1

[12]Locationinpatent:schemeortableRatcliff,Jessica;Kuduk-Jaworska,Janina;Chojnacki,Henryk;Nemykin,Victor;Gerasimchuk,Nikolay[InorganicaChimicaActa,2012,vol.385,p.1-11]

[13]Locationinpatent:experimentalpartKhattab,SherineN.;Subirós-Funosas,Ramon;El-Faham,Ayman;Albericio,Fernando[Tetrahedron,2012,vol.68,#14,p.3056-3062]

[14]Hayotsyan,SargisS.;Mkryan,GevorgG.;Aghekyan,AsyaA.;Melikyan,GagikS.[HeterocyclicCommunications,2012,vol.18,#4,p.189-192]

[15]Manidhar,DarlaMark;Kesharwani,RajeshKumar;Reddy,N.Bakthavatchala;Reddy,C.Suresh;Misra,Krishna[MedicinalChemistryResearch,2013,vol.22,#9,p.4146-4157]

[16]Shaik,JeelanBasha;Palaka,BhagathKumar;Penumala,Mohan;Kotapati,KasiViswanath;Devineni,SubbaRao;Eadlapalli,Siddhartha;Darla,M.Manidhar;Ampasala,DinakaraRao;Vadde,Ramakrishna;Amooru,G.Damu[EuropeanJournalofMedicinalChemistry,2016,vol.107,p.219-232]

[17]Shaik,JeelanBasha;Palaka,BhagathKumar;Penumala,Mohan;Eadlapalli,Siddhartha;DarlaMark,Manidhar;Ampasala,DinakaraRao;Vadde,Ramakrishna;AmooruGangaiah,Damu[ChemicalBiologyandDrugDesign,2016,p.43-53]

[18]Basha,ShaikJeelan;Mohan,Penumala;Yeggoni,DanielPushparaju;Babu,ZinkaRaveendra;Kumar,PalakaBhagath;Rao,AmpasalaDinakara;Subramanyam,Rajagopal;Damu,AmooruGangaiah[MolecularPharmaceutics,2018,vol.15,#6,p.2206-2223]

[19]Karteek,S.Durga;Reddy,A.Gopi;Tej,M.Bhuvan;Rao,M.V.Basaveswara[RussianJournalofOrganicChemistry,2021,vol.57,#2,p.272-282][Zh.Org.Khim.]

2058-74-4    15029-32-0   
2-1-Methyl-2-oxo-1,2-dihydro-indol-(3Z)-ylidene-3-morpholin-4-yl-3-oxo-propionitrile 

[1]Ukhov,S.V.;Konshin,M.E.[ChemistryofHeterocyclicCompounds,1992,vol.28,#12,p.1379-1381][KhimiyaGeterotsiklicheskikhSoedinenii,1992,#12,p.1611-1613]

15029-32-0    611-09-6   
3-Morpholin-4-yl-2-5-nitro-2-oxo-1,2-dihydro-indol-(3Z)-ylidene-3-oxo-propionitrile 

[1]Ukhov,S.V.;Konshin,M.E.[ChemistryofHeterocyclicCompounds,1992,vol.28,#12,p.1379-1381][KhimiyaGeterotsiklicheskikhSoedinenii,1992,#12,p.1611-1613]

[1]Shklyaev,V.S.;Aleksandrov,B.B.;Mikhailovskii,A.G.;Vakhrin,M.I.[ChemistryofHeterocyclicCompounds,1989,vol.25,#9,p.1038-1041][KhimiyaGeterotsiklicheskikhSoedinenii,1989,#9,p.1239-1242]

[1]Tatke,D.R.;Seshadri,S.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1983,vol.22,#12,p.1197-1199]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 15029-32-0
Tags:15029-32-0 Molecular Formula|15029-32-0 MDL|15029-32-0 SMILES|15029-32-0 N-Cyanoacetylmorpholine